Delivery Order SPE2DB22D3016-SPE2DB26FAAG8
- Not listed
- The Defense Logistics Agency awarded a $34.77K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of May 13, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine ER 600 mg tablets (100-count) on August 7, 2025, with a ceiling value of $12,813.16. This firm fixed price delivery order, which represents non-competitive procurement, is scheduled for completion by August 8, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded under the...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count packaging) under a firm fixed-price contract valued at $7,215.32. The award, which must be completed by September 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units, with a ceiling value of $3,449.47 and firm fixed pricing. This delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 1, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a continuation of the vendor's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 150 mg tablets (100-count units) with a ceiling value of $2,169.26. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified vendor. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.46 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Oxcarbazepine 150 mg, an anticonvulsant medication commonly used to treat neurological conditions. This firm fixed-price delivery order, issued on September 22, 2025, with completion expected by September 23, 2025, represents a non-competitive set-aside purchase that leverages AmerisourceBergen's existing contract vehicle with DLA. The contractor will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250ml quantities, with a ceiling value of $1,442.97. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAG8Delivery Order
The Defense Logistics Agency awarded a $16,858.83 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Oxcarbazepine ER 300 mg tablets in quantities of 100 units. The contract represents a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical medical supply support to federal healthcare systems, particularly the Department of Defense and military healthcare networks. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices to support military healthcare programs worldwide. The current delivery order for Oxcarbazepine ER, a neurological treatment medication, exemplifies the company's role as a key vendor for federal pharmaceutical procurement and fulfillment of specific medical supply requirements across the defense health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 10/21/25 |